However, the FAT1‐HR subgroup showed a significantly lower five‐year OS rate than the FAT1‐LR subgroup among HPV (−) HNSCC patients (P = 0.003; Fig. 2B). Here, FAT1 is linked to head and neck squamous cell carcinoma.